Cyclophosphamide, epirubicin, high-dose folinic acid and 5-fluorouracil (super-FEC) as first-line chemotherapy for advanced breast cancer: Preliminary results
Author:
Publisher
Elsevier BV
Subject
Oncology
Reference30 articles.
1. Chemotherapy of breast cancer;Perlow;Med Oncol Tumor Pharmacother,1984
2. Chemotherapy versus chemoimmunotherapy (CAV vs. CAFVP vs. CMF each + MER) for metastatic carcinoma of the breast: a CALGB study;Aisner;J Clin Oncol,1987
3. High-dose chemotherapy for breast cancer;Carbone;J Clin Oncol,1987
4. High-dose combination alkylating agent chemotherapy with autologous bone marrow support for metastatic breast cancer;Eder;J Clin Oncol,1986
5. Evaluation of high-dose versus standard FAC chemotherapy for advanced breast cancer in protected environment units: a prospective randomized study;Hortobayi;J Clin Oncol,1987
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. A Retrospective Series of Long-Term Survivors of Metastatic Breast Cancer in Complete Remission;Oncology;2005
2. Laevofolinic acid, 5-fluorouracil, cyclophosphamide and escalating doses of epirubicin with granulocyte colony-stimulating factor support in locally advanced and/or metastatic breast carcinoma: a phase I-II study of the Southern Italy Oncology Group (GOIM);British Journal of Cancer;1995-11
3. A Phase I—II Study of Cyclophosphamide, Epidoxorubicin, Levofolinic Acid/5-Fluorouracil and Recombinant Human Granulocyte Colony Stimulating Factor in Metastatic Breast Carcinoma;Acta Oncologica;1994-01
4. Phase II trial of 5-fluorouracil and folinic acid in the treatment of advanced breast cancer;Breast Cancer Research and Treatment;1994
5. Weekly 5-fluorouracil and high-dose folinic acid in combination with epidoxorubicin as first-line therapy in advanced breast cancer: a phase II study;Cancer Chemotherapy and Pharmacology;1994
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3